Apr 7
HQL · abrdn Life Sciences Investors · Documents
Market Cap
$527.88M
Shares
30.41M
Volume · Nov 6
37.09K
Avg daily vol (3M)
132.55K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2026
2025
Apr 14
Proxy statement
DEF 14A
Meeting May 28, 2025
Proxy statement
2024
May 24
Proxy statement
DEFA14A
Proxy statement
Apr 22
Proxy statement
DEF 14A
Meeting Jun 25, 2024
Proxy statement
2023
Oct 5
Proxy statement
DEFA14A
Proxy statement
Oct 4
Proxy statement
DEFA14A
Proxy statement
Oct 2
Proxy statement
DEFA14A
Proxy statement
Sep 15
Proxy statement
DEFA14A
Proxy statement
Sep 15
Proxy statement
DEFA14A
Proxy statement
Sep 13
Proxy statement
DEFA14A
Proxy statement
Sep 12
Current report
8-K
Events of Sep 6
Change of auditor
Sep 5
Proxy statement
DEFA14A
Proxy statement
Aug 29
Proxy statement
DEFA14A
Proxy statement
Aug 22
Proxy statement
DEFA14A
Proxy statement
Aug 14
Proxy statement
DEFA14A
Proxy statement
Aug 11
Proxy statement
DEFA14A
Proxy statement
Jul 28
Proxy statement
DEFA14A
Proxy statement
Jul 18
Proxy statement
DEFA14A
Proxy statement
Jul 11
Proxy statement
DEFA14A
Proxy statement
Jul 10
Proxy statement
DEF 14A
Meeting Aug 14, 2023
Proxy statement
Jun 27
Proxy statement
PRE 14A
Meeting Aug 14, 2023
Proxy statement
Apr 11
Proxy statement
DEF 14A
Meeting Jun 8, 2023
Proxy statement
2022
Apr 20
Proxy statement
DEFA14A
Proxy statement
Apr 12
Proxy statement
DEF 14A
Meeting Jun 9, 2022
Proxy statement
2021
Apr 13
Proxy statement
DEF 14A
Meeting Jun 10, 2021
Proxy statement
2020
Apr 14
Proxy statement
DEF 14A
Meeting Jun 11, 2020
Proxy statement
Showing 1–26 of 26 documents